Cancer in adolescents and young adults
| Cancer in adolescents and young adults | |
|---|---|
| Synonyms | AYA cancer |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Varies by cancer type; may include fatigue, pain, weight loss, lumps, swelling |
| Complications | Metastasis, secondary cancer, psychosocial issues |
| Onset | Ages 15–39 |
| Duration | Varies by cancer type and stage |
| Types | Leukemia, lymphoma, melanoma, sarcoma, testicular cancer, breast cancer, thyroid cancer, colorectal cancer |
| Causes | Genetic factors, environmental factors, lifestyle factors |
| Risks | Family history, genetic predisposition, radiation exposure, smoking, obesity |
| Diagnosis | Medical imaging, biopsy, blood tests |
| Differential diagnosis | Other benign tumors, infectious diseases |
| Prevention | Healthy lifestyle, vaccination, screening |
| Treatment | Surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy |
| Medication | Chemotherapeutic agents, targeted drugs, hormonal therapy |
| Prognosis | Varies by cancer type and stage; generally better than older adults |
| Frequency | Approximately 70,000 cases per year in the United States |
| Deaths | Varies by cancer type; overall survival rates improving |
Cancer in Adolescents and Young Adults (AYA) refers to the unique medical and psychosocial challenges faced by individuals diagnosed with cancer between the ages of 15 and 39. This age group experiences specific types of cancers and faces distinct challenges in diagnosis, treatment, and survivorship compared to younger children and older adults. The most common cancers in this group include leukemia, lymphoma, testicular cancer, breast cancer, and sarcomas.
Epidemiology[edit]
Cancer in AYAs is less common than in older adults but represents a significant burden due to the number of productive life years it affects. The incidence of cancer in this age group has been increasing over the past few decades for reasons that are not entirely understood. Despite this increase, survival rates have also improved due to advances in cancer treatment and supportive care.
Diagnosis[edit]
Diagnosing cancer in AYAs can be challenging. Symptoms often mimic those of more common, less serious conditions, leading to delays in diagnosis. Furthermore, AYAs may lack access to regular healthcare, making it less likely for them to seek help early. Awareness campaigns and education for both healthcare providers and the public are crucial to improving early diagnosis rates.
Treatment[edit]
Treatment for AYAs with cancer often requires a multidisciplinary approach, including medical oncology, surgical oncology, and radiation oncology. The unique biological characteristics of cancers in this age group, as well as the patients' developmental stage, necessitate tailored treatment protocols. Fertility preservation is an important consideration, as many cancer treatments can affect fertility.
Psychosocial Aspects[edit]
The diagnosis of cancer in AYAs can have profound psychosocial impacts. Issues such as interruption of education or career, financial challenges, changes in physical appearance, and fertility concerns can significantly affect mental health. Support services, including counseling and peer support groups, are vital components of comprehensive cancer care for AYAs.
Survivorship[edit]
Survivorship care is an essential aspect of cancer care for AYAs, addressing the long-term effects of cancer and its treatment. This includes monitoring for secondary cancers, managing chronic health issues related to treatment, and providing support for psychosocial issues. Survivorship care plans should be individualized, taking into account the specific needs and experiences of AYA cancer survivors.
Research and Advocacy[edit]
Research into cancers affecting AYAs is growing, focusing on understanding the biological differences of cancers in this age group, improving treatment outcomes, and addressing the unique psychosocial needs of these patients. Advocacy efforts aim to increase awareness, improve access to specialized care, and support research funding for AYA cancers.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian